For 3 years already, led by Emmanuelle Deponge, a LallianSe Expert, involved in the selection of projects, #NBGH has entrusted us with the 360° Sessions in a format specifically organized to meet the challenges of the program
These sessions do not just challenge all of the company’s development areas. They also aim to build the foundations of the #equitystory for the development of business projects!
March 2023
At LallianSe, each support is tailor-made,flexible and agile to meet the key development challenges of our clients and partners, here with NBGH
#NBGH asked #LallianSe to pilot the « 360° Sessions » at the instigation of Emmanuelle Deponge, involved in the selection of projects while being #LallianSe Expert for several years.
These sessions challenge all areas of business development: from planning to execution, from regulatory strategy to organization, thanks to LallianSe’s unique track record and Emmanuelle’s #expertise.
For the 3rd consecutive year, Julie contributed to the co-design workshops in e-health & rares diseases organized by the Rare Diseases Foundation.
At #LallianSe, our #experience in constructing investment theses allows us to highlight the most relevant dimensions and milestones of each project, thus providing necessary insight and value creation for investors.
Remember, we announced to you at the beginning of the year the renewal of our #collaboration with the Rare Diseases Foundation as part of the co-design workshops in e-health & rare diseases for projects in the early study phase.
What are the objectives of these workshops?
🎯 Help in the initiation of innovative projects by identifying the necessary resources and key steps for their implementation 🎯 Adopt a collaborative approach and stimulate inter-business dialogue from the first ideas 🎯 Promote discussions with partners and Experts who master the subject
Why is this important to us?
💪 To encourage the emergence of innovations driven by healthcare professionals 🙌 To support the improvement of the care and life path of people suffering from a rare disease 🤝 To be consistent with our values and our field initiatives
It is as a LallianSe Expert that Julie Rachline was able to bring her #expertise to the ‘Brain Mouv’ project led by Iris Marolleau.
Our collaborations arise from a mutual desire to transform innovation and develop it in care.
Between @Hôtel-Dieu and its Apéros de l’Innovation, the #Agora of digital care, #APInnov and more recently #ASIIA (Association of Innovative Companies from AP-HP), so many initiatives which are starting a innovative dynamic, promote and support the creation of #startups, in connection with one of the largest (eco)health systems in Europe, the #APHP.
In the deployment of #LallianSeEducation initiatives and the #DUGBM University Diploma, the organization of which is partly operated by #LallianSe alongside Pierre Mozer & Alain Sezeur, this #training addresses all the #issues of research and of biomedical innovation as well as the themes of the #valorization of research.
Last module for the class of 2024 with the contribution of four LallianSe #Experts who presented strategic interventions:
Finally, the last session of the DU highlighted the ABG – Association Bernard Gregory, member of the LallianSe network and represented by Vincent Mignotte, about the initiation and development of its #network
Sharing our experiences by supporting the training of tomorrow’s professionals: this is the approach we favor, in addition to our other activities, to build the environment favorable to the #success of #innovations.
Alongside Pierre Mozer and Alain Sezeur, LallianSe as part of the #LallianSeEducation, contributes to the management and organization of the University Diploma Valorization of Biomedical Research by Sorbonne University.
One of the first encouraged developments was to transform the traditional “lunch meeting” between students and speakers, allowing them to create a professional network. We opted for a dynamic #cocktail format, and we had the chance to witness a real live #emulsion !
The DU GBM #community is growing and will continue to develop to bring out the #talents of tomorrow within innovative #health industries.
A big thank you to Cuisine mode d’emploi for delighting us
Our #hospital #immersion within the #GHU Sorbonne University has allowed us to create, for 7 years already, #synergies to build the environment favorable to the success of #health innovations. Since 2023, as part of the #LallianSeEducation initiatives, the new class of the #Sorbonne University Diploma has returned to school during this training in the Valorization of Biomedical Research.
This diploma, supervised by Julie Rachline alongside Pierre Mozer and Alain Sezeur, is aimed at all researchers, engineers, administrators, health professionals, doctoral students… and others!
The training addresses all the issues of biomedical research and innovation as well as the issues of valorization beyond being a first step in initiating and developing your network.
In the deployment of its hospital immersion initiatives and LallianSeEducation, the University Diploma of Sorbonne, DU GBM, whose management is ensured by Julie Rachline and whose organization is partly operated by LallianSe, we are proud to announce a new synergy made by LallianSe: a cross partnership between the DU GBM of Sorbonne Université, and the Bioentrepreneurs Launchpad program launched by the Imagine Institute – X-HEC Entrepreneurs & Université Paris Cité, Université Paris-Saclay & ESCP Business School.With very complementary approaches, one for acculturation to valorization and the other for the creation of startups, we decided to combine these training courses in order to offer 2 tailor-made courses. Contact us at du.gbm@lallianse.com now!
March 2023
Under the leadership of Pierre Mozer and Alain Sezeur as part of the #Sorbonne University Diploma: training in the Valorization of Biomedical Research co-directed by Julie Rachline, we had the opportunity to organize a #tableronde dedicated to # #health issues.
The future is promising, the significant #opportunities and the many challenges to develop new economic models, build infrastructure, deploy solutions that meet the needs expressed by caregivers and patients alike, but also from everyone. healthcare innovation industry. Impossible to escape this fundamental #transformation: join the movement, and don’t hesitate to participate next year in #DUGBM !
In September 2022 we announced the #lancement de LallianSe Education. In the deployment of this new initiative, and our hospital #immersion within the #GHU Sorbonne University allowing us to create #synergies for 6 years already to develop the environment favorable to the success of innovations in #health, we are proud to announce the first module of the #Sorbonne University Diploma: training in the Valorization of Biomedical Research
This #training, led by Julie Rachline alongside Pierre Mozer and Alain Sezeur, is aimed at all researchers, engineers, administrators, health professionals, doctoral students… and others!
Anxious to know the social, economic and regulatory environment to value and develop #innovation through a research-industry partnership, to create an innovative company, as well as to researchers in training wishing to pursue a career in the health industries.
The training addresses all the #issues of research and biomedical innovation as well as the techniques of enhancement beyond being a first stone to initiate and develop your #network.
The diploma training addresses all the #issues of research and biomedical innovation as well as the techniques of enhancement beyond being a first stone to initiate and develop your #network. The other two weeks of modules are scheduled for next March!
An opportunity to share the experience of BrainTale, our flagship initiative.
Through concrete examples of the relationship between a CEO and an investor, represented by Virginie MIATH, Director of Investments at Capital Grand Est, participants were able to leave with a guide to good practices: the 10 commandments of the investment thesis.
Entrepreneurial success is not a linear journey… Are you wondering how to bounce back and maintain enthusiasm despite the pitfalls of the entrepreneurial journey?
To answer these questions and yours, the #LallianSe team is delighted to announce the 5th edition of the 𝐄𝐦𝐛𝐮̂𝐜𝐡𝐞𝐬 𝐝𝐞 𝐥’𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: a testimony, followed by an open and taboo-free exchange.
We will have the pleasure of welcoming Laurent Levy co-founder and CEO of Nanobiotix : a pioneering company and leader in nanomedicine having developed a revolutionary approach to the treatment of cancer.
Since its creation almost 20 years ago, Nanobiotix has gone through both original and more traditional development stages, before finalizing a strategic agreement with the big pharma in 2023.
Join us to cultivate #resilience, learn to transform difficulties into opportunities and capitalize on this sharing of experiences to adjust your approach to the future.
Meet us on Monday April 22, 2024 at 7pm
In person, at the Pitié-Salpêtrièrehospital
Event by registration onlyembuche@lallianse.com Donation of 12€ minimum for food expenses
First integrated into the LallianSe #community through our #events, Carole Neves joined our #community of #Experts in residence as Sparring and Operating partner, particularly with EVerZom and international clients.
Our common ambition to support the creation and development of start-ups, combined with Carole‘s keen #expertise in rare diseases, gene therapies and other innovative products, allows us to offer a 360° vision of the challenges of business development and health products
Ultimately, it is a #synergy that supports the startup’s value creation and actively contributes to its success.
The Institut Curie, Institut Pasteur & LallianSe invite* you to a quirky and exclusive professional evening, where laughter mixes with innovation!
A theatrical improvisation match around the theme of promoting research, organized jointly by the teams of the Institut Pasteur, the Institut Curie and LallianSe, forming 3 teams of 3 candidates, formed in advance. Each team, made up of Entrepreneur/Researcher, Investor and representative of a technology transfer organization, – where each does not play their role – will compete in comparative improvisation around a point of negotiation of a letter of intention.
Between experiences, fantasies and realities, investors, entrepreneurs / researchers and development players take the stage to share funny situations – or less so! – and react on themes of negotiations, differences and allow everyone to identify the point of view of others.
Using the applause meter, the victorious team will be designated, and the refereeing, according to the rules of theatrical improvisation, will allow the orchestration of an entertainment lasting approximately 1h15, punctuated by dynamic exchanges with the guests, before continue with a light cocktail planned for the occasion.
Standing ovations to our team captains and partners:: Jérémie, Alexandre et Julie, as well as to our referee Helene Chausson from BrainTale, who orchestrated this evening with talent and originality.
Finally, we thank the numerous spectators who came and the event was sold out. We are sorry not to have been able to register everyone, but….
We are delighted to announce that the victorious blue team, decided by public vote, will defend their title in our next edition! #Staytuned 🏆
Initiated as #SparringPartner following the arrival of Sébastien IVA as Chairman of the Management Board in 2020, the translation of the vision, the outline of the roadmap and the articulation of the investment thesis have gradually strengthened the agenda of interactions and existing support.
A real pleasure to support the evolution of #Fabentech towards its position as European leader!
Very happy to share today this excellente news for the development of #Biomunex.
For more than 5 years, with one of our key Expert-in-Residence, Stéphane MILOT, with Loïc MOULARD also for a few months, at the helm of the outsourced Financial Department, as well as our support around different strategic and operational perspectives, #LallianSe is pleased to contribute to the success of Biomunex.
Congratulations to the entire team for starting this clinical study ! 👏
